1) Takatsuki K (ed):Adult T-cell Leukemia. Oxford University Press, New York,1994
2) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans:Human immunodeficiency viruses and human T-cell lymphotropic viruses. IARC Monographs on the evaluation of carcinogenic risks to humans, IARCPress, Geneva,1996
3) 渡邉俊樹,上平憲,山口一成(編):HTLV-1と疾患.文光堂,2007
4) 塚崎邦弘:成人T細胞性白血病・リンパ腫の治療の進歩.高久史磨,溝口秀昭,坂田洋一,他(編):Annual Review 血液2007.中外医学社,pp170-182,2007
5) Lymphoma Study Group (1984-1987):Major prognostic factors of patients with adult T-cell leukemia- lymphoma:a cooperative study. Leuk Res 15:81-90,1991
6) Shimoyama M:Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 79:428-437,1991
7) Tawara M, Hogerzeil SJ, Yamada Y, et al:Impact of p53 aberration on the prognosis of Adult T-cell Leukemia/Lymphoma. Cancer Lett 234:249-255,2006
8) Hino S, Katamine S, Miyata H, et al:Primary prevention of HTLV- in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 13(Suppl):S199-203,1996
9) Tsukasaki K, Utsunomiya A, Fukuda H, et al:VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma:Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25:5458-5464,2007
10) Fukushima T, Miyazaki Y, Honda S, et al:Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 19:829-834,2005
11) Takasaki Y, Tsukasaki K, Iwanaga M, et al:A long-term study on indolent Adult T-cell leukemia/lymphoma (ATLL). 49th American Society of Hematology abstr,2007